Roche meanwhile already has the comfort of one positive result for giredestrant from the coopERA study in post ... which was reported at last year's ESMO meeting. In that trial, the SERD performed ...

In its favour is that its drug did hit the mark when used as a neoadjuvant therapy for post-menopausal women with HR+ early breast cancer in the coopERA ... at last year's ESMO meeting.

Shares of Sutro Biopharma (NASDAQ:STRO) fell by 17% in September after the company's ESMO (European Society for Medical Oncology) update. 3-year performance isn't looking much better at -81% ...

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024. Topics covered include the use of AI in breast cancer ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

ISLAMABAD (Dunya News) - Prime Minister Shehbaz Sharif on Wednesday welcomed the "esteemed guests at the Shanghai Cooperation Organisation (SCO) summit." In his address at the plenary session, the ...

Nicolas Girard, MD, PhD, discusses patient-reported outcomes from the LUMINOSITY trial of telisotuzumab vedotin in NSCLC.